Clinical Trials Browser

NCT01871766 2025-12-17

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Phase 2 Active not recruiting

115 enrolled

Sarcoma

Rhabdomyosarcoma

NCT00265798 2025-08-20

Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate

Phase 2 Active not recruiting

38 enrolled 9 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT02050919 2022-03-21

Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma

Phase 2 Completed

20 enrolled 14 charts

Sarcoma

NCT00880542 2020-08-10

Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery

Phase 2 Terminated

7 enrolled 5 charts

Sarcoma

NCT00621686 2018-05-08

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 2 Completed

54 enrolled 8 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00238121 2015-11-20

Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer

Phase 2 Completed

56 enrolled 11 charts

GynecologicSarcoma

Recurrent Uterine Sarcoma

NCT00837148 2015-11-20

Sorafenib and Dacarbazine in Soft Tissue Sarcoma

Phase 2 Completed

37 enrolled 6 charts

Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma

NCT01804374 2015-06-17

SERIO

Phase 2 Completed

38 enrolled

Sarcoma

Sarcoma, Osteosarcoma

NCT00245102 2014-05-23

Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

Phase 2 Completed

147 enrolled 13 charts

Sarcoma

Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00217620 2014-05-15

S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas

Phase 2 Completed

51 enrolled 9 charts

Sarcoma

Hemangiopericytoma, Malignant, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma

NCT00330421 2014-04-30

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

Phase 2 Completed

15 enrolled 7 charts

Sarcoma

Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00597493 2013-06-24

Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM

Phase 2 Completed

32 enrolled 9 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

NCT00889057 2013-03-28

Sorafenib in Relapsed High Grade Osteosarcoma

Phase 2 Completed

35 enrolled

Sarcoma

Osteosarcoma

NCT01091207 2012-01-20

Sorafenib for Imatinib/Sunitinib-failed GIST

Phase 2 Completed

39 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00406601 2010-09-02

BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas

Phase 2 Completed

69 enrolled

Sarcoma

NCT00874874 2009-12-24

Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery

Phase 2 Unknown

96 enrolled

Sarcoma

Hemangiosarcoma, Sarcoma